| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
13.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
8,851 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$2,012,670 |
$2,012,670 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
11,609 |
11,681 |
63,744 |
167,262 |
| Total Sell Value |
$1,891,338 |
$1,906,248 |
$12,326,709 |
$40,328,387 |
| Total People Sold |
1 |
2 |
4 |
7 |
| Total Sell Transactions |
1 |
2 |
8 |
20 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hollingshead James |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
3,062 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
7,977 |
|
- |
|
| Scannell Timothy J |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
23,579 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
14,498 |
|
- |
|
| Minogue Michael R |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
3,549 |
|
- |
|
| Lyle Corinne H |
Director |
• • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,029 |
4,283 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2020-05-26 |
4 |
D |
$182.63 |
$851,604 |
D/D |
(4,663) |
18,601 |
|
- |
|
| Lyle Corinne H |
Director |
– • – |
2020-05-01 |
4 |
AS |
$196.82 |
$169,856 |
D/D |
(863) |
3,254 |
|
- |
|
| Lyle Corinne H |
Director |
– • – |
2020-04-30 |
4 |
AS |
$195.54 |
$155,650 |
D/D |
(796) |
4,117 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• – – |
2020-04-16 |
4 |
AS |
$193.76 |
$280,758 |
D/D |
(1,449) |
11,447 |
|
- |
|
| Kapples John W. |
SVP, Secretary and GC |
• – – |
2020-04-01 |
4 |
D |
$159.17 |
$153,122 |
D/D |
(962) |
10,191 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2020-03-06 |
4 |
AS |
$177.49 |
$184,945 |
D/D |
(1,042) |
6,948 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFO |
• • – |
2020-02-28 |
4 |
D |
$189.97 |
$477,205 |
D/D |
(2,512) |
23,764 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2020-02-28 |
4 |
AS |
$190.00 |
$126,160 |
D/D |
(664) |
12,896 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2020-02-27 |
4 |
AS |
$182.01 |
$2,480,194 |
D/D |
(13,627) |
13,560 |
|
- |
|
| Christensen Bret |
EVP and CCO |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$64,624 |
D/D |
(359) |
23,264 |
|
- |
|
| Petrovic Shacey |
President and CEO |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$202,331 |
D/D |
(1,124) |
120,921 |
|
- |
|
| Mcmillan Wayde D. |
EVP, CFO |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$65,344 |
D/D |
(363) |
26,276 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$162,549 |
D/D |
(903) |
44,535 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$54,183 |
D/D |
(301) |
27,187 |
|
- |
|
| Benjamin Eric |
SVP, R&D, New Prod Dev & Comm |
• • – |
2020-02-26 |
4 |
D |
$180.01 |
$25,561 |
D/D |
(142) |
15,117 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2020-02-21 |
4 |
D |
$212.31 |
$1,358,359 |
D/D |
(6,398) |
45,438 |
|
- |
|
| Alpuche Charles |
EVP & Chief Operating Officer |
• • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,818 |
51,836 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2020-02-21 |
4 |
D |
$212.31 |
$878,539 |
D/D |
(4,138) |
27,488 |
|
- |
|
| Spears Michael P |
SVP, RA and Compliance |
• • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,572 |
31,626 |
|
- |
|
1123 Records found
|
|
Page 13 of 45 |
|
|
3.15 (1.85%) 
